Background-Noninvasively assessed pulmonary pressure elevations and left ventricular (LV) diastolic dysfunction are associated with increased mortality in adults with sickle cell disease, but their relationship to exercise intolerance has not been evaluated prospectively. Methods and Results-Echocardiography, 6-minute walk distance, hemolytic rate, and serum concentrations of ferritin and erythropoietin were evaluated in a cohort of 483 subjects with homozygous hemoglobin S in the US and UK Walk-Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy (Walk-PHaSST) study. Tricuspid regurgitation velocity, which reflects systolic pulmonary artery pressure, was 2.7 to Ͻ3.0 m/s (meanϮSD, 2.8Ϯ0.1) in 26% of the subjects and Ն3.0 m/s (meanϮSD, 3.4Ϯ0.4) in 11%. The LV lateral E/eЈ ratio, which has been shown to reflect LV filling pressure in other conditions but has not been studied in sickle cell disease, was significantly higher in the groups with tricuspid regurgitation velocity Ն2.7 m/s. Increased hemolysis (PϽ0.0001), LV lateral E/eЈ ratio (Pϭ0.0001), blood urea nitrogen (Pϭ0.0002), and erythropoietin (Pϭ0.002) were independently associated with an increased tricuspid regurgitation velocity. Furthermore, female sex (PϽ0.0001), older age (PϽ0.0001), LV lateral E/eЈ ratio (Pϭ0.014), and tricuspid regurgitation velocity (Pϭ0.019) were independent predictors of a shorter 6-minute walk distance. Conclusions-Echocardiography-estimated elevated pulmonary artery systolic pressure and LV lateral E/eЈ ratio were independently associated with poor exercise capacity in a large cohort of patients with sickle cell anemia. Controlled trials investigating whether strategies to prevent or delay pulmonary hypertension and/or LV diastolic dysfunction will improve exercise capacity and long-term outcomes in sickle cell anemia should be considered. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00492531.
S
ickle cell anemia is caused by homozygote substitution of valine for glutamic acid at position six of the ␤-globin chain of hemoglobin, resulting in mutant hemoglobin S polymerization with deoxygenation. This is the central event that leads to the acute and chronic complications of sickle cell disease (SCD), including vaso-occlusive episodes and hemolysis. Similar to other conditions such as HIV, cardiopulmonary complications were not prominent in SCD when thera-peutic options were limited and life expectancy was short. Now that treatment and survival have improved, patients are manifesting right and left heart dysfunction. 1, 2 Clinical studies using echocardiography or right heart catheterization to assess cardiopulmonary function have shown abnormal elevation in pulmonary pressures [3] [4] [5] [6] and left ventricular (LV) diastolic dysfunction (LVDD), 2, 6 with each independently associated with increased mortality in adults with SCD. [2] [3] [4] [5] 
Clinical Perspective on p 1460
Laboratory, transgenic mouse, and clinical studies suggest that there is a clinical syndrome of hemolysis-associated increased pulmonary artery pressure. [7] [8] [9] [10] [11] [12] [13] [14] [15] Cross-sectional and longitudinal studies report associations between the degree of hemolysis and markers of pulmonary artery pressure in SCD. 3-5,16 -18 Nevertheless, the clinical importance of elevated pulmonary pressures in SCD and their relationship to hemolysis have been challenged in recent reports, raising the need for further study in large multicenter cohorts. 19 -22 Exercise intolerance occurs in patients with SCD, 16, 23 and is correlated with elevated pulmonary pressures in previously reported case series. 18, 23 However, it is unclear how often exercise limitations are due to pulmonary abnormalities, including pulmonary hypertension (PH) and resultant right ventricular dysfunction, impaired LV filling, an inadequate heart rate response to exercise, or additional factors not fully explored. In SCD patients evaluated for suspected PH, increased LV filling pressures are not infrequently observed by right heart catheterization. 6 In the general population, several studies have shown that Doppler echocardiography can estimate LV filling pressures, 24, 25 and that abnormalities are associated with exercise intolerance. 26, 27 An association with a putative echocardiographic marker of LV filling pressure and exercise intolerance in children with sickle cell anemia has also been reported. 18 The Walk-Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy (Walk-PHaSST) study was designed to develop a large, multicenter, observational cohort of patients with a tricuspid regurgitation velocity (TRV) ranging from normal to Ն3.0 m/s and to conduct a smaller interventional trial of treatment with sildenafil in the subset of patients with a TRV Ն2.7 m/s. This observational cohort is the largest prospective study to date evaluating echocardiography in adults and adolescents with SCD. The purpose of this study was to noninvasively assess the relationship of echocardiographic markers of PH and LVDD with functional impairment as assessed by the 6-minute walk test.
Methods

Selection of Subjects
The Walk-PHaSST study was designed and supervised by an Executive Committee composed of investigators. Data management and analyses were performed by a contract organization working with the Executive Committee. The authors wrote the manuscript and made the decision to submit it for publication. All authors contributed to the writing of the manuscript and had full access to the data and analyses. The authors vouch for the accuracy and completeness of this report. Subjects were recruited at 9 US centers and 1 UK center. Local institutional review boards or ethics committees approved the protocol, and written informed consent was obtained from all study subjects (http://www.clinicaltrials.gov; unique identifier, NCT00492531). Subjects with sickle cell hemoglobinopathy (hemoglobin SS, SC, and S␤-thalassemia and other less common sickle cell hemoglobinopathies) Ն12 years of age and at steady state were eligible for the observational study; 720 were enrolled from February 2008 to June 2009. Steady state in the study subjects was defined by their usual state of health, and no participant was enrolled until at least 3 weeks had elapsed since any acute pain event, hospitalization, or emergency room visit. Subjects were evaluated by self-reported history modeled after the National Institutes of Health (NIH) PH screening survey, 3 physical examination, laboratory screening, transthoracic Doppler echocardiography, and the 6-minute walk test. All patients were included in the observational study regardless of estimated pulmonary artery systolic pressure or 6-minute walk distance. The subset of patients recruited into the separate intervention study have been reported elsewhere. 28 To avoid confounders related to sickle genotype, the present report focuses on the 483 subjects with hemoglobin SS who underwent screening in the Walk-PHaSST study; 250 (52%) were female, and the median age was 35 years at enrollment (range, 12 to 69 years).
Laboratory Studies
Routine laboratory tests (complete blood count, reticulocyte count, serum chemistry profile, and lactate dehydrogenase) were performed in the local laboratories of the participating institutions. Serum erythropoietin (R&D Systems, Minneapolis, MN; reference range, 3.3-16.6 IU/L) and ferritin (Ramco Laboratories Inc, Stafford, TX; reference range, 20 -300 ng/mL) were measured with enzyme immunoassays. Hemoglobin F percent was measured by highperformance liquid chromatography (Ultra Resolution System, Trinity Biotech).
Echocardiograms
Echocardiography was performed at the participating institutions and read centrally in the National Heart, Lung, and Blood Institute (NHLBI) echocardiography core laboratory. Cardiac measurements were performed according to American Society of Echocardiography guidelines. 29 We estimated LV ejection fraction from the biplane Simpson method. 29 Left atrial volume was measured with the biplane method of disks incorporating apical 4-and 2-chamber views. 30 We calculated LV mass and LV mass index using the formula described by Devereux et al. 31 Mitral inflow recordings were obtained with the pulsed Doppler sample volume at the level of the mitral leaflet tips during maximal opening in diastole. Tissue Doppler recordings were measured with sample volumes at both the septal mitral annulus and lateral mitral annulus. The ratio of early diastolic LV inflow velocity to lateral mitral annular velocity (LV lateral E/eЈ) was calculated as an estimate of LV filling pressure. 24 We used TRV to estimate pulmonary artery systolic pressures and assessed TRV in the parasternal long-and short-axis and apical 4-chamber views as previously described. 3 
Statistical Analysis
Principal component analysis was used to derive a hemolytic component from 4 markers of hemolysis: lactate dehydrogenase (site-adjusted values), aspartate aminotransferase (site-adjusted values), total bilirubin, and reticulocyte percent. The new variable had a mean of 0 (SDϭ1.48) and predicted 54% of variation among all 4 variables (eigenvalueϭ2.18).). Linear regression analysis was used to adjust lactate dehydrogenase and aspartate aminotransferase for site. In this analysis, the residuals (which are the source of variation after site adjustment) were used to calculate the new site-adjusted values. Continuous variables with a skewed distribution were converted to a normal distribution using natural log or square root. Univariate relationships were determined with the Pearson or Spearman correlation coefficient. The study prospectively defined 3 TRV groups: Ͻ2.7, 2.7 to Ͻ3.0, and Ն3.0 m/s. The nonparametric test for trend was used to assess the relationship of different variables to the 3 TRV groups. Multiple linear regression was used to assess the independent effect of predictors on TRV, LV lateral E/eЈ ratio, and 6-minute walk distance. Variables were entered into the regression models if they had a significant univariate association with the dependent variable (higher TRV categories, LV lateral E/eЈ ratio, 6-minute walk distance). For continuous variables, we tested whether a linear relationship or a nonlinear relationship was the best approach to analysis. We used pairwise correlation between predictors and the variance inflation factor to assess collinearity in each model. We checked for an interaction between site and predictors in each model. The final model was selected with a stepwise approach. Data are reported as mean or geometric mean with the 95% confidence interval. Missing values were the result of a lack of laboratory or echocardiographic observations in random subgroups of patients. The study outcomes of TRV, LV lateral E/eЈ ratio, and 6-minute walk distance did not differ according to whether variables were missing. A value of PϽ0.05 was considered statistically significant. Analyses were performed with Stata 10.1 software (StataCorp, College Station, TX).
Results
Characteristics of the Walk-PHaSST Cohort
Clinical and echocardiographic characteristics are shown in Table 1 . Of the 483 participants, 52 (10.8%) were 12 to 20 years of age.
Doppler-Defined Pulmonary Pressure Elevations
Distribution of Clinical and Echocardiography Variables According to Tricuspid Regurgitation Velocity Groups
The TRV was measurable in 435 of the subjects (90.1%) with a median of 2.6 m/s (range, 1.6 -4.6 m/s). Of these 435, the TRV was 2.7 to Ͻ3.0 m/s in 124 (28.5%) and Ն3.0 m/s in 53 (12.2%). Among the participants 12 to 20 years of age, the TRV was measurable in 44 (84.6%); of these, the TRV was Ն3.0 m/s in 4 (9.1%). Univariate analysis showed that patients in the higher TRV groups were older and had higher systemic systolic pressures and systemic pulse pressures, lower resting systemic arterial oxygen saturations, and lower hemoglobin concentrations (Table 2) . They had higher serum concentrations of erythropoietin, blood urea nitrogen, and creatinine and higher values for the hemolytic component. By echocardiography, the left atrial volume index, LV mass index, and LV lateral E/eЈ ratio were higher among patients with increased TRV. Figure 1A depicts the linear relationship between TRV and the hemolytic component; Figure 1B depicts the relationship between TRV and the LV lateral E/eЈ ratio.
Independent Predictors of Increased Tricuspid Regurgitation Velocity in Multivariate Analysis
In multiple linear regression analysis, a 1-SD increase in the hemolytic component was independently associated with an estimated 0.09-m/s increase in the TRV (PϽ0.0001), a natural log increase in LV lateral E/eЈ ratio with a 0.19-m/s increase (Pϭ0.001), a natural log increase in the blood urea nitrogen with a 0.10-m/s increase (Pϭ0.0002), and a natural log increase in the serum erythropoietin concentration with a 0.07-m/s increase (Pϭ0.002; Table 3 ). The hemoglobin concentration did not have a significant independent relationship with elevated TRV.
Doppler Assessment of Left Ventricular Diastolic Function
We used the LV lateral E/eЈ ratio to estimate LVDD in this study, but its usefulness for this purpose in the setting of SCD hemodynamics has not been prospectively studied.
Variables Associated With Increasing Left Ventricular Lateral E/e Ratio in Univariate Analysis
The LV lateral E/eЈ ratio was reported in 436 of the subjects (90%) with a median of 6.4 (range, 2.2-29.5). Increasing age, higher body mass index, higher systolic blood pressure, lower hemoglobin concentration, and higher serum creatinine concentration were associated with higher LV lateral E/eЈ ratios (Table 4) . Additionally, the natural log LV left lateral E/eЈ ratio correlated with TRV (nϭ415; rϭ0. 24 Figure 2 depicts the relationship between the natural log LV lateral E/eЈ ratio and hemoglobin concentration.
Independent Predictors of Higher Left Ventricular Lateral Wall E/e Ratio in Multivariate Analysis
In a multiple linear regression analysis, lower hemoglobin concentration (Pϭ0.0001), older age (Pϭ0.001), higher body mass index (Pϭ0.001), and higher systolic blood pressure (Pϭ0.007) were each independently associated with a higher natural log LV lateral E/eЈ ratio (Table 5) .
Six-Minute Walk
Variables Associated With 6-Minute Walk Distance in Univariate Analyses
The 6-minute walk distance correlated inversely with the TRV categories. The meanϮSD distance was 458Ϯ91, 438Ϯ98, and 409Ϯ96 m in patients with velocities of Ͻ2.7, 2.7 to Ͻ3.0, and Ն3.0 m/s, respectively (Pϭ0.001; Figure  3A ). Six-minute walk distance correlated positively with younger age, male sex, lower body mass index, and higher hemoglobin concentration (Table 6) , and was inversely related to the natural log LV lateral wall E/eЈ ratio (RϭϪ0.22, PϽ0.0001; Figure 3B ).
Independent Predictors of 6-Minute Walk Distance
In a multivariate analysis, both TRV (Pϭ0.019) and LV lateral E/eЈ (Pϭ0.014) were independent predictors of a lower 6-minute walk distance (Table 7) . Additional predictors were older age and female sex.
Discussion
The findings from this large, prospective, multicenter study of patients with sickle cell anemia demonstrate an independent association between high hemolytic rate and an increased estimated pulmonary artery systolic pressure as assessed by Doppler echocardiography. The findings additionally demonstrate an independent association between worse anemia and LV lateral E/eЈ ratio. Furthermore, in this study, elevations of both TRV and LV lateral E/eЈ ratio were associated with functional impairment as assessed by the 6-minute walk test. The mean 6-minute walk distance among the hemoglobin SS patients with TRV Ն3.0 m/s in this study was similar to the distance reported in patients with chronic thromboembolic PH. 32 Although we have not analyzed mortality in Walk-PHaSST, these findings relating exercise capacity to estimated pulmonary artery systolic pressure and LV lateral E/eЈ ratio in this large cohort parallel our previous observations with regard to mortality from the NIH. 2,3 They also provide support in adults for our recent findings in children that echocardiographic estimates of elevated right ventricular systolic pressure and LVDD may be associated with reduced exercise capacity. 18 Thus, our present findings are supportive of echocardiographic screening for PH and LVDD in SCD and suggest that these observations may have functional relevance in terms of assessing exercise capacity. Increased TRV, as estimated by Doppler echocardiography, is a useful screening test for suspected PH, including in patients with SCD, 6, 7, 23 and is a marker of increased mortality in adults with SCD. [2] [3] [4] [5] In confirmed PH (diagnosed by right heart catheterization), approximately one half of the cases were attributable to increased pulmonary vascular resistance meeting criteria for pulmonary arterial hypertension, with the majority of the remainder having pulmonary venous hypertension attributed to LVDD. 23 This large international study confirms independent associations of increased TRV with hemolytic severity, elevated LV filling pressure, renal dysfunction, and high circulating erythropoietin concentrations in SCD patients. The independent association of increased blood urea nitrogen with an increased TRV is consistent with our previous report of an association of renal disease with elevated TRV. 3 The independent association of increased erythropoietin with increased TRV is also consistent with some previous observations, [33] [34] [35] but in contrast to others. 36, 37 Circulating erythropoietin concentrations reflect the degree of tissue hypoxia, 38 and the association of a greater level of erythropoietin with a higher TRV may serve as a marker of the degree of tissue hypoxia, which appears to be associated with the development of PH in other conditions. 39 Additionally, erythropoietin has functions other than the stimulation of erythropoiesis, such as regulation of the development of endothelial progenitor cells and angiogenesis 40, 41 ; the inducement of such processes could contribute to vascular remodeling and the risk of developing PH. The circulating erythropoietin concentrations could also be a marker for potential contributions of increased erythropoiesis to increased pulmonary artery pressure. Developing erythroblasts release placental growth factor into the circulation. Placental growth factor upregulates the production of inflammatory mediators and the potent vasoconstrictor endothelin-1. Studies in animals and humans suggest a potential causative role for placental growth factor in PH. 42 In addition, LVDD, as assessed by Doppler echocardiography, is a marker of increased mortality in adults with SCD. 2 The results of the present study confirm that echocardiographic markers of LVDD are prevalent in sickle cell anemia and point to independent associations of older age, worse anemia, higher systolic blood pressure, and elevated body mass index with an elevated LV lateral E/eЈ ratio. The degree Variables entered into the model were age, systolic blood pressure, pulse pressure, oxygen saturation, hemoglobin, erythropoietin, BUN, creatinine, hemolytic component, left atrial volume index, left ventricular mass index, and LV lateral E/eЈ. Eleven outliers were removed; R 2 ϭ0.25. Each of the following variables could substitute for hemolytic component in the multiple linear regression model: total bilirubin (natural log): nϭ373, ␤ϭ0.06, 95% CIϭ0.02 to 0.11; aspartate aminotransferase* (natural log): nϭ368, ␤ϭ0.07, 95% CIϭ0.01 to 0.13; Reticulocyte percent (square root): nϭ350, ␤ϭ0.05, 95% CIϭ0.02 to 0.09. Lactate dehydrogenase* (natural log): nϭ348, ␤ϭ0.10, 95% CIϭ0.04 to 0.17.
*Site adjusted.
of anemia, rather than the rate of hemolysis, appeared to be the stronger independent predictor of LVDD, as assessed by the LV lateral E/eЈ ratio in the present study. This observation is in contrast to elevated TRV, for which the strongest independent predictor was the rate of hemolysis rather than the degree of anemia. Anemia and elevated body mass index have also been reported as risk factors for LVDD in other settings. 43, 44 This study has a number of limitations. First, Doppler estimation of LV filling pressure is challenging in the setting of preserved LV systolic function. 24, 45, 46 Patients with SCD have chronic anemia, high cardiac output, and volume over- load, which may affect the interpretation of noninvasive measures. Doppler parameters of LV diastolic function have not been reported in SCD patients undergoing invasive measurement of LV filling pressure. Second, the study did not include the measurement of inflammatory markers, such as high-sensitivity C-reactive protein. Sickle cell disease is associated with chronic inflammation, which itself has been implicated in the cardiopulmonary complications of this disorder. 47 Third, reference ranges for markers of hemolysis, including lactate dehydrogenase, varied considerably among the sites participating in this study. The use of principal component analysis for developing a hemolytic component that reflects shared variability among several markers of hemolysis has the advantage of permitting adjustment for each participating center in developing the hemolytic component. Fourth, our findings do not fully explain PH, LVDD, and limited 6-minute walk distance in sickle cell anemia. The multivariate models presented in Tables 3, 5 , and 7 could explain 25%, 15%, and 34%, respectively, of these measurements. Further research is needed to more fully understand these complications.
Moving forward, clinical trials may be warranted to evaluate strategies to prevent or delay the development of PH and LVDD in sickle cell anemia, but there are challenges in targeting hemolysis and the degree of anemia. The interventions assessing a Gardos channel inhibitor and the phosphodiesterase type 5 inhibitor sildenafil were associated with increased vaso-occlusive complications. 48, 49 Hydroxyurea administration, which reduces hemolysis, raises hemoglobin concentration, and increases hemoglobin F percentage, has not been associated with a lower TRV in a number of large cross-sectional studies. 3, 16 Prospective studies are needed to evaluate whether hydroxyurea is effective in reducing the development of PH and/or LVDD. Blood transfusions could also be expected to improve left-sided cardiac function and the 6-minute walk distance in hemoglobin SS patients. Long-term transfusion therapy may therefore be an ideal approach to prevent and treat both abnormalities, but would be complicated by iron overload and alloimmunization. We suggest that hydroxyurea, blood transfusion, and novel approaches be investigated in patients at increased risk of developing PH and/or elevated LV lateral E/eЈ ratio because these complications independently predict poor outcome in patients with sickle cell anemia.
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